Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Dimethoxy quinazoline derivative WHI-P180 inhibits mast cell mediator release

Sep. 11, 1998

DuPont identifies SP-904 as potent and selective CRF1 receptor antagonist

Sep. 11, 1998

DDE-131: new apoptosis-inducing antitumor agent from WHI

Sep. 11, 1998

Merck Frosst reveals discoveries in the field of COX-2 inhibitors at ACS meeting

Sep. 11, 1998

Biaryl uricosuric agents developed at Kotobuki

Sep. 11, 1998

Kotobuki selects development candidate from novel series with selectivity for COX-2

Sep. 11, 1998

Novartis dives into renin inhibitor research; one compound selected for clinical testing

Sep. 11, 1998

Early clinical results reported for osutidine, an H2 antagonist from Toyama

Sep. 10, 1998

Antisecretory and antiulcer effects of S-0509 characterized in rats

Sep. 10, 1998

KW-5139 effective for reducing gastric stasis following pancreatoduodenectomy

Sep. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...